Brain Slice Explants to Predict Drug Response in Brain Tumors
- Conditions
- Central Nervous System Tumor
- Registration Number
- NCT05978557
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
In order to participate in this study a subject must meet all of the eligibility criteria<br>outlined below.<br><br>Inclusion Criteria:<br><br> 1. Written informed consent obtained to participate in the study and HIPAA<br> authorization for the release of personal health information or written assent and<br> parental consent for pediatric subjects or surrogate consent provided by the<br> subject's legally authorized guardians.<br><br> 2. A diagnosis of a tumor residing in the central nervous system with surgery plan to<br> have surgical resection.<br><br> 3. The subject is willing and able to comply with study procedures based on the<br> judgment of the investigator or protocol designer.<br><br>Exclusion Criteria:<br><br> 1. All subjects must not meet any of the following exclusion criteria prior to<br> enrollment to participate in this study:<br><br> Any serious medical or psychiatric disorder that would interfere with the subject's<br> ability to give informed consent.<br><br> 2. Incarcerated individuals.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of specimens yielding scores
- Secondary Outcome Measures
Name Time Method The scalability of evaluable specimens